tirzepatide or ozempic GLP-1 drugs such as semaglutide and are transforming obesity and diabetes care in India, but experts warn that improper use could lead to significant muscle loss. A new India-specific consensus highlights TrimRX | Semaglutide vs Tirzepatide:

Escalation rates vary by clinical context and individual response

The company also announced a decision to initiate phase 3a development of oral semaglutide, a GLP-1 analogue formulated as a once-daily tablet for the treatment of type 2 diabetes.

A must have for us

Generally, studies show that glutathione levels can start to rise within a few days of consistent NAC supplementation, with more noticeable effects after 12 weeks of daily use

The most robust clinical evidence arguably originates from the large cardiovascular outcomes trials (CVOTs) completed for most GLP-1 RAs, of which the latest showed a significant relative risk reduction (RRR) of 39% (HR) with once-weekly efpeglenatide on HF requiring hospitalisation, corroborating a meta-analysis which found a significant RRR across eight GLP-1 RA CVOTs of 11%

We reviewed the electronic medical records to assess whether the subjects who stopped using dulaglutide later resumed insulin therapy or switched to OHAs after discontinuing dulaglutide over the 6 months